Upload Avatar (500 x 500)
Qin Liu
Medical School
Nanjing University
Jiangsu
Language: Chinese, English
Malignant Tumors
Therapeutic Vaccines
Tumor Immunotherapy
New Drugs
Clinical Practice
Basic Research
Translational Research
Personalized Neoantigen
Nanovaccine
Drug Resistance
Areas of Focus
- Therapeutic vaccines for malignant tumors
- Construction and application of new tumor immunotherapeutic drugs
Academic Background & Achievements
- PhD: Nanjing University Medical School
- Jiangsu Province '333' Project third-level training object
- Jiangsu Province Young Medical Key Talent
Publications
- Bifunctional Fusion Membrane-Based Hydrogel Enhances Antitumor Potency of Autologous Cancer Vaccines by Activating Dendritic Cells, Ke Y, Zhu J, Chu Y, Cen L, Fu Y, Fan X, Shao J, Li R, Yu L, Liu B, Liu Q, 2022
- Benefits of an immunogenic personalized neoantigen nanovaccine in patients with high-risk gastric/gastroesophageal junction cancer, Liu Q, Chu Y, Shao J, Qian H, Yang J, Wei J, Liu B, 2022
- Versatile Protein Coronation Approach with Multiple Depleted Serum for Creating Biocompatible, Precision Nanomedicine, Wang C, Xue M, Liu X, Chen J, Jiang M, Zheng L, Ma R, Ding C, Tao Y, Zhang H, Liu Q, Da Huo, 2022
- Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles, Liu Q, Li R, Qian H, Wei J, Xie L, Shen J, Yang M, Qian X, Yu L, Jiang X, Liu B, 2013
- Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma, Chu Y, Qian L, Ke Y, Feng X, Chen X, Liu F, Yu L, Zhang L, Tao Y, Xu R, Wei J, Liu B, Liu Q, 2022
- Personalized cancer neoantigen vaccines come of age, Chu Y, Liu Q, Wei J, Liu B, 2018
- An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer, Chen X, Liu F, Yu X, Li L, Yan J, Chen X, Liu Q, Liu B, 2022
- Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination, Chu Y, Li R, Qian L, Liu F, Xu R, Meng F, Ke Y, Shao J, Yu L, Liu Q, Liu B, 2021
- Superior Antitumor Efficacy of IFN-α2b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer, Liu Q, Zhang D, Qian H, Chu Y, Yang Y, Shao J, Xu Q, Liu B, 2020
- Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer, Zhang D, Chu Y, Qian H, Qian L, Shao J, Xu Q, Yu L, Li R, Zhang Q, Wu F, Liu B, Liu Q, 2020
Awards
- 2021: First Prize of Jiangsu Province Medical New Technology Introduction Award for the establishment and application of gastric cancer-specific immunotherapy technology based on neoantigens
- 2019: First Prize of Jiangsu Province Science and Technology Progress Award for new discoveries and translational research in precision medicine for gastric cancer based on molecular markers
- 2019: First Prize of Jiangsu Province Medical Science and Technology Award for precision individualized treatment of gastric cancer
- 2016: First Prize of Jiangsu Province Medical New Technology Introduction Award for the individualized application of nanomedicine based on physiological drug resistance of malignant tumors
- 2015: Ministry of Education Science and Technology Progress Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer
- 2015: Second Prize of Jiangsu Province Science and Technology Progress Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer
- 2015: Third Prize of Chinese Medical Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer
- 2015: Second Prize of Jiangsu Province Medical Science and Technology Award for basic clinical research on new systems for targeted nanomedicine delivery for gastric cancer
